Form 8-K - Current report:
SEC Accession No. 0001193125-25-115533
Filing Date
2025-05-08
Accepted
2025-05-08 08:10:25
Documents
16
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d932196d8k.htm   iXBRL 8-K 28845
2 EX-99.1 d932196dex991.htm EX-99.1 56624
7 GRAPHIC g932196dsp001.jpg GRAPHIC 5461
  Complete submission text file 0001193125-25-115533.txt   263105

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sln-20250508.xsd EX-101.SCH 3534
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sln-20250508_def.xml EX-101.DEF 14077
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sln-20250508_lab.xml EX-101.LAB 23244
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sln-20250508_pre.xml EX-101.PRE 14924
18 EXTRACTED XBRL INSTANCE DOCUMENT d932196d8k_htm.xml XML 5865
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-39487 | Film No.: 25924003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)